Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Meiluwei Biotechnology is a specialized biotechnology company based in Jinan, China, focusing on the research, development, and large-scale production of high-end pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company is a prominent supplier of nucleosides, nucleotides, and phosphoramidites, which are essential building blocks for the synthesis of oligonucleotide therapeutics and mRNA vaccines. Their product portfolio supports global pharmaceutical companies and research institutions in the fields of antiviral drug development and gene therapy. Meiluwei operates advanced R&D and manufacturing facilities, ensuring high-purity chemical synthesis for complex molecular structures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinan Meiluwei Biotechnology.